ClinicalTrials.gg
Sign In
CompletedNCT02852447Updated Feb 23, 2017

The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve

An observational study in Antimullerian Hormone, Ovarian Cysts and Antral Follicle Count, sponsored by Corporacion Parc Tauli. Completed at 1 site in Spain. Open to female participants aged 15 Years to 40 Years. Per ClinicalTrials.gov, last updated 2017-02-23.

Sponsored by Corporacion Parc Tauli · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
15 Years to 40 Years
Sex
Female
01

Study summary

The main objective is to evaluate the ovarian reserve after laparoscopic cystectomy.

The secondary objective is the analysis of predictors of change in the ovarian reserve after surgery

02

Conditions studied

  • Antimullerian Hormone
  • Ovarian Cysts
  • Antral Follicle Count

Browse trials for

03

In context

Ovarian Cysts

76 studies on the registry are indexed under Ovarian Cysts; 15 are open to participants now.

This study's enrollment of 30 is below the median of 155 across 26 observational studies indexed under Ovarian Cysts.

Browse Ovarian Cysts studies →

Lead sponsor

Corporacion Parc Tauli is the lead sponsor of 166 studies on the registry; 24 are open to participants now.

Browse Corporacion Parc Tauli studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with bening ovarian cyst and requiring surgical removal

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with non endometriosis ovarian cysts
  • Age between 15-40 years
  • Regulars menses
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients with Previous surgery,
  • Patients with infertility,
  • Patients with endometriosis or
  • Patients with suspicious of malignance
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. differences in the ovarian reserve before and after surgery by Antimullerian Hormone

    Time frame: 3 months

  2. differences in the ovarian reserve before and after surgery by Antral Follicle Count

    Time frame: 3 months

Secondary outcomes

  1. Ovarian Size (mm)

    Time frame: 3 months

  2. Time of surgery (minutes)

    Time frame: 3 months

  3. Age (years)

    Time frame: 3 months

  4. BMI in kg/m2

    Time frame: 3 months

07

Study locations

1 site
  • Corporació Sanitària Parc Tauli
    Sabadell, Barcelona 08208, Spain
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2014, a primary completion of Oct 2016 and a completion of Dec 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2016
First posted
Aug 2, 2016
Start
Nov 2014
Primary completionActual
Oct 2016
CompletionActual
Dec 2016
Last update
Feb 23, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02852447
Lead sponsor
Corporacion Parc Tauli
Responsible party
Laura Costa-Canals (MD, Corporacion Parc Tauli) — Principal investigator
First posted
Aug 2, 2016
Start date
Nov 2014
Primary completion
Oct 2016
Completion
Dec 2016
Last update
Feb 23, 2017
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Ovarian Cysts →

Other studies from this sponsor

Corporacion Parc Tauli →

Start the discussion